发布于: Android转发:0回复:0喜欢:0

$Enanta制药(ENTA)$


ENTA Announces Sale of a Portion of Global Royalties on MAVYRET(U.S.)/MAVIRET (ex-U.S.) to OMERS Life Sciences for $200 Million